Bertin Pharma - Institutionnel
logo
Select your search
Contact us
Molecular Targets for Cancer: Aim straight!

Molecular Targets for Cancer: Aim straight!

Molecular Targets for Cancer: Aim straight!
Date : Since Feb 18, 2016
Place :
Bioreagent

Introducing Exclusive MS2Plex® Technology new Receptor Tyrosine Kinase Quantification Kit: RTK C

Benefits
> Key regulators of Development Cell Growth
> No or Low activity in normal cells
> Hyperactivated or upregulated in malignant cells

RTK C kit for 21 different targets:
IGFR, VEGFR1, PDGFRa, FAK1, FAK2, FGFR1, FGFR2, FGFR3, FGFR4, MET, ERBB2, ERBB3, ERBB4...


See all targets

top

Bertin Pharma - Institutionnel
Follow Us
Linkedin Youtube Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 260
Any questions? Contact us

Headquarters:
Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations

Newsletter

Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions